Protein Prenylation, Part A

Fuyu Tamanoi is a biochemist who has served on the UCLA School of Medicine and UCLA College faculty since he joined the Department of Microbiology, Immunology & Molecular Genetics in 1993. He became a full professor in 1997.

Chapter 1: Protein prenylation: A perspective on initial discoveriesJohn GlomsetChapter 2: Insights into the function of prenylation from nuclear lamin farnesylationMichael SinenskyChapter 3: Posttranslational Processing of Nuclear Lamins Brandon S. J. Davies, Catherine Coffinier, Shao H. Yang, Hea-Jin Jung, Loren G. Fong, and Stephen G. YoungChapter 4: Prenylated Proteins in Peroxisome BiogenesisRobert Rucktäschel, Rezeda Mirgalieva, Ralf ErdmannChapter 5: Lipid Modification of Ras Superfamily GTPases: Not Just Membrane GlueEmily J. Chenette,, Channing J. DerChapter 6: Heterogeneous Prenyl Processing of the Heterotrimeric G protein Gamma SubunitsJohn HildebrandtChapter 7: Farnesylation versus geranylgeranylation in G-protein-mediated light signaling Masahiro Okada , Hidetoshi Kassai, Yoshitaka FukadaChapter 8: Organization and function of the Rab prenylation and recycling machineryKirill Alexandrov, Yaowen Wu, Wulf Blankenfeldt, Herbert Waldmann, Roger S. Goody Chapter 9: Protein prenylation and CaaX processing in plantsShaul YalovskyChapter 10: Posttranslational isoprenylation on tryptophan residue in Bacillus subtilisMasahiro Okada, Fumitada Tsuji, Youji SakagamiChapter 11: Global analysis of prenylated proteins by the use of a tagging via substrate approachLai N. Chan, Fuyuhiko TamanoiChapter 12: Global Identification of Protein Prenyltransferase Substrates: Defining the Prenylated ProteomeCorissa L. Lamphear, Elaina A. Zverina, James L. Hougland, Carol A. FierkeChapter 13: Structural biochemistry of CaaX protein prenyltransferasesMichael A. Hast , Lorena S. BeeseChapter 14: Genetic Analyses of the CAAX Protein Prenyltransferases in MiceMOHAMED X. IBRAHIM, OMAR M. KHAN, MARTIN O. BERGOChapter 15: Farnesyl Transferase Inhibitors: From Targeted Cancer Therapeutic to a Potential Treatment for ProgeriaW. Robert Bishop, Ronald Doll, Paul Kirschmeier